A phase I/II study on intensification of combined cisplatin and cyclophosphamide in ovarian cancer using rGM-CSF

Sean Kehoe; C Poole; Andrew Stanley; H Earle; G Blackledge

A phase I/II study on intensification of combined cisplatin and cyclophosphamide in ovarian cancer using rGM-CSF

Sean Kehoe, C Poole, Andrew Stanley, H Earle, G Blackledge

Cancer and Genomic Sciences

Research output: Contribution to journal › Article › peer-review

7 Citations (Scopus)

Original language	English
Pages (from-to)	537-540
Journal	British Journal of Cancer
Volume	69
Issue number	3
Publication status	Published - Mar 1994

Keywords

Phase i/ii
combined cisplatin
cyclophosphamide
ovarian cancer
rGM-CSF

ASJC Scopus subject areas

Medicine(all)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{b9f6b090de6e41d5bf5ae4847956a68c,

title = "A phase I/II study on intensification of combined cisplatin and cyclophosphamide in ovarian cancer using rGM-CSF",

keywords = "Phase i/ii, combined cisplatin, cyclophosphamide, ovarian cancer, rGM-CSF",

author = "Sean Kehoe and C Poole and Andrew Stanley and H Earle and G Blackledge",

year = "1994",

month = mar,

language = "English",

volume = "69",

pages = "537--540",

journal = "British Journal of Cancer",

issn = "0007-0920",

publisher = "Cancer Research UK",

number = "3",

}

TY - JOUR

T1 - A phase I/II study on intensification of combined cisplatin and cyclophosphamide in ovarian cancer using rGM-CSF

AU - Kehoe, Sean

AU - Poole, C

AU - Stanley, Andrew

AU - Earle, H

AU - Blackledge, G

PY - 1994/3

Y1 - 1994/3

KW - Phase i/ii

KW - combined cisplatin

KW - cyclophosphamide

KW - ovarian cancer

KW - rGM-CSF

M3 - Article

SN - 0007-0920

VL - 69

SP - 537

EP - 540

JO - British Journal of Cancer

JF - British Journal of Cancer

IS - 3

ER -